High rates of undiagnosed HIV were found amongst adolescents (aged between 10 – 19) across five high-burden countries in southern Africa, while the low rates of...
Dolutegravir-based treatment was superior to treatment based on efavirenz or a boosted protease inhibitor in children and adolescents, both as first-line or second-line treatment, a large...